Treatment Planning

Treatment planning maps directly to the AANPCB's Plan domain, which accounts for 26% of scored questions. This domain tests whether you can establish collaborative, patient-centered, evidence-based treatment plans — including pharmacological and nonpharmacological interventions, appropriate level of care, referrals, and patient education.

The AANPCB's Plan domain goes beyond medication selection. It tests your ability to provide informed consent (risks, benefits, alternatives, and side effects of psychopharmacotherapies), monitor adherence while considering barriers (financial, cultural, side effects), determine appropriate level of care, and facilitate care transitions. Safety planning, crisis intervention, and when to escalate from outpatient to higher levels of care are explicitly tested.

The Evaluate domain (20%) is closely related — it tests whether you can assess treatment effectiveness and modify the plan based on patient outcomes. Together, Plan and Evaluate represent 46% of the exam. Questions often present a patient already on treatment and ask for the appropriate next step: continue current plan, augment, switch, add psychotherapy, change level of care, or re-assess the diagnosis.

• ✕Jumping to medication changes before establishing whether the current treatment had adequate dose and duration. The AANPCB Evaluate domain specifically tests whether you know to assess treatment adequacy before modifying the plan — typically 4-6 weeks at therapeutic dose for antidepressants.
• ✕Neglecting nonpharmacological treatments. The AANPCB lists both 'pharmacology' and 'nonpharmacological therapies' as separate knowledge areas. Treatment plans that are exclusively pharmacological miss the integrated approach the exam expects — psychotherapy, lifestyle interventions, and psychoeducation should be considered.
• ✕Not matching treatment intensity to acuity. The Plan domain tests level-of-care decisions: outpatient, intensive outpatient, partial hospitalization, inpatient. The exam tests nuanced risk stratification, not reflexive hospitalization for every mention of suicidal ideation.
• ✕Ignoring patient barriers in treatment planning. The AANPCB explicitly tests monitoring adherence while considering barriers — financial constraints, cultural factors, side effects, transportation. A technically correct medication choice can be the wrong answer if the patient cannot access or tolerate it.
• ✕Forgetting that the Plan domain includes referrals and care coordination. Not every question expects you to manage everything yourself — knowing when to refer to a specialist, consult with a collaborating physician, or coordinate with social services is a tested competency.